States’ Restrictions On Sales Of Weight Loss OTCs, Supplements Stalled By Vetoes, Lobbying
Executive Summary
States’ efforts on prohibiting sales to minors of OTC diet drugs as well as weight loss and bodybuilding supplements to minors didn’t advance in 2022, setting stage for more showdowns in 2023.
You may also be interested in...
Supplement Industry Slams New York’s Reasons To Age-Restrict Sales, Expects Other States To Follow
Sales of supplements and OTC drugs labeled for weight loss and bodybuilding supplements in New York will be prohibited to consumers younger than 18 starting in April 2024. “Once one state does it, what you see is that other states sort of look at that,” says CRN CEO Steve Mister.
State Lawmakers Likely To Deal Questions About Oral Phenylephrine Into 2024 Legislation Deck
State government authority is limited to make changes concerning OTC sales, including oral products with phenylephrine. “As we've learned in the past, that hasn't stopped them before. We're going to be monitoring this very closely going into next year,” says CHPA state legislature lobby chief Carlos Gutierrez.
Age Restriction For Weight-Loss Supplement Sales Vetoed In California But Still In States' Crosshairs
“States need to now take notice and ensure these draconian policies never again see the light of day,” says NPA head Daniel Fabricant. CRN, neutral on restriction passed in California before governor’s veto, urges lawmakers to responsibly balance consumer safety with access to supplements.